Literature DB >> 30428460

Rhabdomyolysis among Critically Ill Combat Casualties: Long-Term Outcomes.

Tarra Faulk1, Lauren E Walker1, Jeffrey T Howard2, Jud C Janak3, Jonathan A Sosnov4, Ian J Stewart5,6.   

Abstract

BACKGROUND: Although rhabdomyolysis has been associated with acute kidney injury and mortality in the short term, the long-term consequences of an episode of rhabdomyolysis remain unknown. We sought to identify the long-term outcomes of rhabdomyolysis, including mortality, renal function, and incidence of hypertension (HTN), among service members initially admitted to the intensive care unit after sustaining a combat injury in Iraq or Afghanistan between February 1, 2002 and February 1, 2011.
METHODS: Information on age, sex, injury severity score, mechanism of injury, serum creatinine, burn injury, presenting mean arterial pressure, and creatine kinase were retrospectively collected and analyzed for 2,208 patients. Standard descriptive tests were used to compare characteristics of patients with and without rhabdomyolysis. Competing risk Cox proportional hazards models were performed to assess the associated risk of rhabdomyolysis with both HTN and poor renal function.
RESULTS: While rhabdomyolysis was associated with HTN on univariate analysis (hazard ratio [HR] 1.30, 95% CI 1.03-1.64; p = 0.029), this difference did not persist on multivariable analysis (HR 1.27, 95% CI 0.99-1.62; p = 0.058). The median estimated glomerular filtration rate (eGFR) was 119 (interquartile range [IQR] 103-128) among those with rhabdomyolysis, compared with 108 (IQR 94-121) in the group without rhabdomyolysis (p < 0.001).
CONCLUSION: After adjustment, patients with rhabdomyolysis were not at an increased risk of HTN compared to patients without rhabdomyolysis. eGFR was paradoxically higher in patients with rhabdomyolysis. There was no association found between rhabdomyolysis and mortality.
© 2018 Published by S. Karger AG, Basel.

Entities:  

Keywords:  Combat injury; Hypertension; Rhabdomyolysis; Trauma

Mesh:

Year:  2018        PMID: 30428460     DOI: 10.1159/000494337

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  3 in total

Review 1.  Experimental models of acute kidney injury for translational research.

Authors:  Neil A Hukriede; Danielle E Soranno; Veronika Sander; Tayla Perreau; Michelle C Starr; Peter S T Yuen; Leah J Siskind; Michael P Hutchens; Alan J Davidson; David M Burmeister; Sarah Faubel; Mark P de Caestecker
Journal:  Nat Rev Nephrol       Date:  2022-02-16       Impact factor: 42.439

2.  Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.

Authors:  Anna Menshikh; Lauren Scarfe; Rachel Delgado; Charlene Finney; Yuantee Zhu; Haichun Yang; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-11

3.  Cilastatin Ameliorates Rhabdomyolysis-induced AKI in Mice.

Authors:  Katsuyuki Matsushita; Kiyoshi Mori; Turgay Saritas; Mahaba B Eiwaz; Yoshio Funahashi; Megan N Nickerson; Jessica F Hebert; Adam C Munhall; James A McCormick; Motoko Yanagita; Michael P Hutchens
Journal:  J Am Soc Nephrol       Date:  2021-08-02       Impact factor: 14.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.